Trial intelligence / Profile preview

Partial Scalp Block vs Fentanyl in Posterior Fossa Surgery

NCT04955236Phase 1Completed

Sponsor
Kasr Al Ainy Hospital
Start
Jul 2021
Primary completion
Nov 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of bupivacaine hydrochloride 0.75% injection in pain (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Systolic blood pressure at time of skin incision. Started Jul 2021; status: completed.

02

Drugs

bupivacaine hydrochloride 0.75% injection
03

Conditions

pain

Beyond the preview

Go deeper on NCT04955236.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04955236.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call